ClinicalTrials.gg
Status unknownNCT03350789Updated Apr 19, 2018

Efficacy and Mechanism of Acupuncture for Chronic Sciatica Using fMRI

An interventional study of Real acupuncture and Sham acupuncture in Chronic Sciatica, sponsored by Kyung Hee University Hospital at Gangdong. Status unknown at 1 site in Korea, Republic of. Open to participants aged 19 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-19.

Sponsored by Kyung Hee University Hospital at Gangdong · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
19 Years to 70 Years
Sex
All
01

Study summary

This research is planned to build a basis about the efficacy and mechanism of acupuncture on pain and emotional disorder in patients with chronic sciatica using fMRI.

Read the detailed description

Clinical research to assess the effect of acupuncture for chronic sciatica on pain and emotional disorder will be processed with randomized, patient-assessor blinding, and sham-acupuncture controlled study design. Sixty eight subjects would be collected and divided into two groups(experimental and placebo, 34 subjects each). Experimental group will undergo with real acupuncture treatment(manual acupuncture + electroacupuncture) and placebo group will undergo with sham acupuncture treatment (acupuncture without skin penetration + electroacupuncture without electrical stimulation) twice a week, for 4 weeks. The effect on parameters related with pain and emotional disorder will be assessed at 1(baseline: just before the beginning of treatment) and 5(primary end point: 1 week after the end of treatment) weeks. Functional magnetic resonance imaging will be also conducted for 52 subjects(experimental and placebo, 20 among 34 subjects each + normal control 12 subjects) at 1 and 5 weeks to seek machanism of acupuncture.

02

Conditions studied

  • Chronic Sciatica

Browse trials for

Keywords

  • acupuncture
  • sciatica
  • MRI, functional
03

In context

Sciatica

149 studies on the registry are indexed under Sciatica; 31 are open to participants now.

This study's planned enrollment of 68 is close to the median of 68 across 122 interventional studies indexed under Sciatica.

Browse Sciatica studies →

Lead sponsor

Kyung Hee University Hospital at Gangdong is the lead sponsor of 23 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adults 19 years of age or more and 70 years of age or less
  • clinical diagnosis of chronic sciatica (pain lasting 3 months or more)
  • 40mm or more of 100mm VAS for bothersomeness due to sciatica
  • volunteers through announcements and advertisements with written

Exclusion criteria

Exclusion Criteria:

  • spinal surgery within the past 6 months
  • diagnosis of specific severe diseases resulting in sciatica: malignant tumor, spinal infection, inflammatory sponlylitis
  • progressive neurological deficit or severe neurological signs
  • other chronic diseases which could disturb the effect of treatments and the results of the study: cardiovascular diseases, diseases, renal diseases, diabetic neuropathy, dementia, epilepsy
  • inadequate or insafe for the treatment of acupuncture/ electroacupuncture: hemorrhagic diseases, medication of anticoagulant, serious diabetes mellitus vulnerable to infections, serious cardiovascular diseases/ pacemaker, metal materials interior of the body
  • currently or might be pregnant
  • severe mental illness
  • currently participating other clinical trials
  • experience of acupuncture or electroacupuncture treatment, or taking medicines which might affect the symptom of pain such as , narcotics, NSAIDs or considered to be inadequate by the investigators within the past week (But they could be included only after going through 2 weeks of wash out period.)
  • difficulty of writing
  • inadeguate or insafe for MRI scanning: claustrophobia, metal materials interor of the body
  • other inadequate subjects assessed by the study investigators
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
68 participants (estimated)

Study arms

  • Experimental
    Real acupuncture

    manual acupuncture + electroacupuncuture on acupoints, twice a week, for 4 weeks

    Device: Real acupuncture

  • Sham comparator
    Sham acupuncture

    sham acupuncture (no skin penetration) + placebo electroacupuncture without electrical stimulation on acupoints, twice a week, for 4 weeks

    Device: Sham acupuncture

Interventions

  • DeviceReal acupuncture

    manual acupuncture(0.25mm diameter x 40mm length, stainless steel, Dongbangacupuncture Inc., Korea) (unilateral GB30) + electroacupuncture(0.25mm diameter x 40mm length, stainless steel, Dongbangacupuncture Inc., Korea) (unilateral EX-B2 (L4 \& L5), BL25, BL23, BL40, GB34), twice a week, for 4 weeks, common approaches for the treatment of chronic sciatica used by doctors of Korean medicine in Korea today

  • DeviceSham acupuncture

    sham acupuncture without skin penetration(0.25mm diameter x 40mm length, stainless steel, Acuprime, UK) (unilateral GB30) + placebo electroacupuncture (0.25mm diameter x 40mm length, stainless steel, Dongbangacupuncture Inc., Korea) without electrical stimulation (unilateral EX-B2, BL25, BL23, BL40, GB34), twice a week, for 4 weeks

06

What researchers measure

Primary outcomes

  1. Visual analogue scale for bothersomeness

    change in visual analoge scale for bothersomeness \[range: 0(better)-100(worse) mm\]

    Time frame: baseline, 1-1, 1-2, 2-1, 2-2, 3-1, 3-2, 4-1, 4-2, 5, and 8 weeks

Secondary outcomes

  1. Visual analogue scale for pain intensity

    change in visual analogue scale for pain intensity \[range: 0(better)-100(worse) mm\]

    Time frame: baseline, 1-1, 1-2, 2-1, 2-2, 3-1, 3-2, 4-1, 4-2, 5, and 8 weeks

  2. Oswestry Disability Index

    change in functional scale: Oswestry Disability Index \[10 items, 0-5 points each, total 0(better) -50(worse) points\]

    Time frame: week 1(before treatment) and week 5(1 week after treatment, primary endpoint)

  3. EuroQol 5-Dimension

    change in quality of life scale: EuroQol 5-Dimension \[5 items, 1-3 points each, total 5(better) -15(worse) points\]

    Time frame: week 1(before treatment) and week 5(1 week after treatment, primary endpoint)

  4. Coping Strategy Questionnaire

    change in coping scale: Coping Strategy Questionnaire \[8 subscales, total 48 items, 0-6 points each, divided into adaptive coping or disadaptive coping, not better or worse\]

    Time frame: week 1(before treatment) and week 5(1 week after treatment, primary endpoint)

  5. Beck Depression Inventory

    change in emotion scale: Beck Depression Inventory \[21 items, 1-4 points each, total 21(better) -84(worse) points\]

    Time frame: week 1(before treatment) and week 5(1 week after treatment, primary endpoint)

  6. State-Trait Anxiety Inventory

    change in emotion scale: State-Trait Anxiety Inventory \[40 items, 1-4 points each, divided into state anxiety or trait anxiety, not better or worse\]

    Time frame: week 1(before treatment) and week 5(1 week after treatment, primary endpoint)

  7. blood oxygenation level dependent in Magnetic Resonance Image, functional

    change in blood oxygenation level dependent of steady state and event-related block design scan run in functional magnetic resonance image. cf. functional magnetic resonance image scan run design: REST(6 min)-TASK1(5 min)-3D T1(5 min)-TASK2(5 min)-DTI(6 min)-TASK3(6 min). REST: steady-state resting scan run. TASK1/2: event-related block design, emotion and pain stimulation model scan run. 2 distinct 5-min experiment blocks (each block-20(5\*4) stimuli (6 sec, inter-stimulus interval: 9 sec); comprised of visual picture(International Affective Picture System: neutral, negative), pain(low back, hand), picture plus pain). 3D T1: structural image acquisition. DTI: diffusion tensor imaging. TASK3: steady state pain model scan run. Low back extension pain model.

    Time frame: week 1(before treatment) and week 5(1 week after treatment, primary endpoint)

  8. Adverse events

    number of participants with adverse events * assessment of severity: mild, moderate, severe * assessment of relation: definitely related, probably related, possibly related, probably not related, definitely not related, unknown

    Time frame: baseline, 1-1, 1-2, 2-1, 2-2, 3-1, 3-2, 4-1, 4-2, 5, and 8 weeks

07

Study locations

1 of 1 sites recruiting
  • Kyung Hee University Hospital at Gangdong
    Seoul, 05278, Korea, Republic of
    Recruiting
08

References and documents

Publications

  • Kim KW, Park K, Park HJ, Jahng GH, Jo DJ, Cho JH, Song EM, Shin WC, Yoon YJ, Kim SJ, Eun S, Song MY. Effect and neurophysiological mechanism of acupuncture in patients with chronic sciatica: protocol for a randomized, patient-assessor blind, sham-controlled clinical trial. Trials. 2019 Jan 16;20(1):56. doi: 10.1186/s13063-018-3164-8. PubMed 30651139 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 19, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03350789
Lead sponsor
Kyung Hee University Hospital at Gangdong
Collaborators
National Research Foundation of Korea
Responsible party
Mi-Yeon Song (Professor, K.M.D., Ph.D., Kyung Hee University Hospital at Gangdong) — Principal investigator
First posted
Nov 22, 2017
Start date
Apr 9, 2018
Primary completion
Jan 2021 (estimated)
Completion
Feb 2021 (estimated)
Last update
Apr 19, 2018

Study contacts

Koh-Woon Kim, Ph.D.
Contact
garson83@hanmail.net
82-2-440-7577
Mi-Yeon Song, Ph.D.
principal investigator · Department of Rehabilitation Medicine of Korean Medicine, Kyung Hee University Hospital at Gangdong

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion